The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Moderna is expected to announce its second-quarter results in the upcoming month, and analysts expect a slight reduction in ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

Explore last week's key healthcare market trends, top gainers & losers, major deals, Trump's tariff plans, FDA approvals, and significant legal updates.

While you are soaking up the summer sun, doctors said you can still get sick, including from two new COVID strains that are going around.